Germany ophthalmic viscosurgical devices market to register substantial gains over 2018-2024, surging prevalence of eye disorders to drive the product demand

Posted on Updated on

Ophthalmic viscosurgical devices market is expected to chart out a remarkable growth path in the years to come, primarily on account of the surging product requirement for age-related cataract treatments. As per reliable statistics, more than 10 million cataract operations are carried out across the globe. The International Agency for the Prevention of Blindness (IAPB) has also gone on record to state that cataract is the leading cause of blindness across the globe. Amidst this backdrop, grim though it may seem, it is quite overt that people suffering from cataract and other ophthalmic disorders will fuel the demand for ophthalmic viscosurgical devices market.

U.S. Ophthalmic viscosurgical devices market, by product, 2017 & 2024 (USD Million)
U.S. Ophthalmic viscosurgical devices market, by product, 2017 & 2024 (USD Million)

Lately, the increasingly changing dietary habits and the prevalence of a hectic, modern lifestyle have led to the widespread occurrence of diabetes. Diabetic people are quite vulnerable to ocular disabilities such as blindness and diabetic retinopathy. As the prevalence of diabetes and diabetes related blindness increases, the global ophthalmic viscosurgical devices industry trends are expected to undergo a massive change.

Elaborating on the pointer of cataract occurrence being a prime influencer of ophthalmic viscosurgical devices market, it is pivotal to mention that cataract surgery accounted for quite some share of the global industry in the year 2017. This is essentially pertaining to the escalating prevalence of the disease in addition to the surging elderly populace across the globe. Apparently, ophthalmic viscosurgical devices market from cataract surgery will register a CAGR of 12.8% over 2018-2024.

Get a Sample Copy of this Report @

How will Germany influence the global ophthalmic viscosurgical devices market statistics?

Germany is touted to come up as one of the most profitable regional arenas for ophthalmic viscosurgical devices market. One of the primary reasons for the same is the growing incidence of ophthalmic disorders in the nation. Not to mention, the presence of organizations such as the German Society of Ophthalmology, the Association of German Ophthalmic Surgeons, and the German Professional Association of Ophthalmologists have been continually implementing national screening programs for glaucoma and other age-related conditions such as macular degeneration. Powered by such initiatives, Germany ophthalmic viscosurgical devices market is forecast to register a CAGR of 12% over 2018-2024.

Enumerating the impact of the U.S. industry on the overall ophthalmic viscosurgical devices market:

The United States is a lucrative ground for not just the North American zone but also for the overall ophthalmic viscosurgical devices market. Indeed, estimates claim that the United States dominated the North America ophthalmic viscosurgical devices market in 2017 with a valuation of USD 156.1 million in 2017 and is apparently expected to depict a similar trend in the years to come.

The primary reason for the expansion of the U.S. ophthalmic viscosurgical devices market is the surging prevalence of diabetes in the region, specifically among the elderly, leading to visual disabilities. Not to mention there has been a tremendous rise in the awareness among the masses with regards to regular eye check-ups, that has further impelled the regional industry. Also, the United States is remnant of extensive healthcare spending on infrastructure and treatment, that would expedite the U.S. ophthalmic viscosurgical devices (OVD) market over 2018-2024.

The competitive landscape of ophthalmic viscosurgical devices market is rather ferocious, encompassing prominent bigwigs such as Alcon, Rayner Intraocular Lenses, Bohus Biotech, Abbott Medical Optics, Johnson & Johnson Vision Care, Bausch & Lomb, Maxigen Biotech, CIMA Technology, and Carl Zeiss Meditec. Pivotal contenders are known to adopt several strategic tactics such as novel product innovation and M&As to thrive in this business space. The declaration of the acquisition of IanTech a firm that concentrates on brainstorming technological solutions for micro-interventional cataract surgeries by Carl Zeiss in 2018 is an instance validating the adoption of strategic tactics in this industry.

Author Name :Saipriya Iyer


Portable homecare oxygen concentrators market to witness phenomenal gains over the years ahead, APAC slated to record the fastest growth

Posted on Updated on

Homecare oxygen concentrators market is witnessing a significant upsurge, driven by the rising number of chronic obstructive pulmonary disease (COPD) patients across the globe. A considerable increase in the number of cigarette smokers and rising exposure to pollution and dust will increase the prevalence of COPD among people. Moreover, the geriatric population is more susceptible to respiratory diseases such as asthma, pulmonary hypertension, fibrosis and are likely to push the growth of homecare oxygen concentrators industry over the years. According to Global Market Insights, Inc., Homecare Oxygen Concentrators Market is projected to witness a CAGR of 12% over the period of 2016-2023 with a revenue target of USD 1.5 billion by 2023.

Product innovation in this market is likely to gain considerable traction with the growing demand for flow technology. Portable oxygen concentrators, liquid oxygen, compressed gas oxygen cylinders are the three trending homecare oxygen concentrators product segments. Compressed gas oxygen cylinder is estimated to generate a revenue of over USD 57 million by 2023, owing to its availability in varied sizes based on the oxygen level requirements. However, the explosion risks associated with these devices coupled with their heavy weight may impede the device market expansion over the coming years.

Germany Homecare Oxygen Concentrators Market size, by product, 2012-2023 (USD Million)
Germany Homecare Oxygen Concentrators Market size, by product, 2012-2023 (USD Million)

Combating the disadvantages such as heavyweight and complex designs, portable homecare oxygen concentrators are witnessing an appreciable adoption rate. Portable homecare oxygen concentrators industry held a major share of over 75% of the global product landscape, and is projected to register a CAGR of 10% over the period of 2016-2023. The compact size of this device and light weight are the complementing factors attracting major revenue for this market.

Get a Sample Copy of this Report @

U.S. almost covered 88% of North America’s homecare oxygen concentrators industry share in 2015 and is slated to attain stupendous growth over the years ahead. Increasing incidence of pulmonary diseases, especially across the elderly population is driving the demand for home health care, which in turn is providing ample opportunities to the regional market. Additionally, favorable insurance policies which cover a large portion of device cost is further acting as a catalyst for the growth trajectory path of the homecare oxygen concentrators market.Huge geriatric base, upgraded living standards, and technologically advanced healthcare infrastructure are the key factors behind the rapid expansion of the APAC homecare oxygen concentrators market. China, India, and Japan are expected to be the major revenue pockets of the regional market.

Japan homecare oxygen concentrators industry generated a revenue of USD 52 million in 2015 and is estimated to cross over USD 138 million by 2023. With strategic collaborations and continuous product upgradation, Asia Pacific market is poised to record maximum growth rate in the coming time frame.

Germany dominated the Europe homecare oxygen concentrators market in 2015, accounting for almost 31% of the regional revenue with a market value of USD 54 million. In the coming time frame too, this country is estimated to experience a striking growth curve at a CAGR of 10% over 2016-2023. Sheer consumer demand for upgraded health care services along with a good number of market players’ availability is stimulating the business expansion in this region.

Continuous efforts on improving the product portfolio and mergers & acquisitions are the major strategies adopted by the industry players to sustain their market position. Some of the prominent players of homecare oxygen concentrators market include Teijen, Covidien, Invacare, Precision Medical, and AirSep.

Author Name :Ojaswita Kutepatil

Protein A resins market to register an appreciable CAGR via antibody purification applications, clinical research laboratories to drive the end-use landscape over 2018-2024

Posted on Updated on

The rise of biologics in antibody engineering & drug development has called for unprecedented growth in the global protein A resins market. The considerable surge in regulatory approvals of monoclonal antibodies from the last few years to combat the robust product demand has also had a commendable implication on the growth statistics of protein A resins market. Monoclonal antibodies, owing to their specificity, efficacy, and stability have become increasingly favorable as therapeutic tools for a variety of conditions, from autoimmune diseases to cancer. Given the popularity of these antibodies for research & diagnostic applications, analysts deem the commercialization potential of global protein A resins market to further tread along a lucrative roadmap in the years ahead.

India Protein A Resins Market, By Application, 2013 – 2024 (USD Million)

India Protein A Resins Market, By Application, 2013 – 2024 (USD Million)

Incidentally, the year 2017 witnessed the overall protein A resins market bagging a valuation of USD 510 million. The vertical is expected to continue its upward growth trajectory in the ensuing years, extensively aided by significant investments and changing R&D trends. An instance bearing testimony to the aforementioned statement is that of Creative Diagnostics, a leading supplier of healthcare research products that has recently launched a new product line of ready-to-use IgM purification reagents. According to reports, these new reagents that guarantee purity & stability, will be particularly used for life science applications and will be made available to researchers all over the world.

Industry experts deem that Protein A & G chromatography continues to lead the life science industries for the purification of IgG. However, in the light of the fact that these methods have proved unsuitable for the purification of IgM antibodies, Creative Diagnostics’ new product portfolio is expected to stimulate protein A resins market trends from antibody purification. Reports in fact affirm that with perpetual developments in the antibody field and increasing demand for therapeutics, antibody purification accounted for the largest revenue share of protein A resins industry in 2017.

Get a Sample Copy of this Report

Speaking along similar lines, the increasing demand for monoclonal antibodies for research and management of chronic diseases from clinical research labs have rendered a positive impact on protein A resins industry share. In fact, if reports are to be believed, clinical research laboratories are touted to be the fastest growing end-use segment of this business sphere. Biopharmaceutical firms form a part of another major end-use segment – these firms extensively uses protein A resins for large-scale purification of monoclonal antibodies. Biopharma firms are likely to witness further lucrative growth ahead as several industry players are putting efforts in launching innovative resins that can reduce costs while improving overall efficacy.

The globally renowned pharmaceutical company Teva has created quite some buzz in protein A resins market lately, claiming that it has increased the life of its Protein A resin thereby reducing costs of manufacturing of monoclonal antibodies. The company has reportedly tweaked its cleaning-in-place (CIP) and sterilization-in-place (SIP) processes that enable a longer life span for its MabSelect SuRe Protein A resins. According to industry experts, increased life of Protein A resin can have direct cost advantage, which in this case accounts for as much as 30% of the total cost of making a monoclonal antibody.

GE Healthcare is another prominent industry player that has launched Protein A resins which it claims to improve monoclonal antibody purification capacity by as much as 40%. Reportedly, the company has introduced MabSelect PrismA and believes that it will be the most preferred option among the biopharmaceutical firms in the capture of monoclonal antibodies. The improved resin is a unique combination of base matrix and a Protein A ligand that enables very high dynamic binding capacities.

This extensive participation of industry players in launching innovative products has indeed proved to be a catalyst in uplifting global protein A resins industry share. These players are further likely to adopt strategies such as partnerships & M&As to garner higher revenue streams and strengthen their footprints in protein A resins market. Experts deem that protein A resins are seen as the gold-standard in monoclonal antibody capture, endowed with undeniable efficacy in disrupting the industry landscape. A presumption validating the same is that of Global Market Insights, Inc., that claims global protein A resins market to hit USD 900 million by 2024.

Author Name :Ojaswita Kutepatil

Digital genome market to observe lucrative gains via R&D sector, U.S. to stimulate industry growth over 2016-2024

Posted on Updated on

On-going research activities along with supportive regulations across the globe will revolutionize digital genome market. The growing implementation of this technology in the field of personalized medical care for efficient disease management will noticeably favor digital genome industry share. According to the Global Market Insights, “Worldwide digital genome market was worth USD 20 billion in 2015 and will exhibit a CAGR of about 9.5% over the coming years of 2016 to 2024.”

The prominent applications of digital genome industry are microbiology, reproductive & genetic, research & development, transportation, and livestock & agriculture sectors. Microbiology application segment accounted for more than 22% of the revenue share in 2015 and will surpass a revenue collection of USD 10 billion by 2024. The growing demand for microbes across clinical, biological, and industrial sectors should drive the revenue. Research & development dominated the application landscape in 2015 and will contribute a revenue of more than USD 23 billion by 2024. The growth can be attributed to heavy investments by private and public sector firms in research activities.

Germany Digital Genome Market size, by product, 2012-2024 (USD Million)
Germany Digital Genome Market size, by product, 2012-2024 (USD Million)

Sequencing and analysis software, one of the product bifurcations of digital genome market, will register an annual growth rate of 9.8% over the period of 2016 to 2024, owing to the increasing efforts to upgrade software packages. High investments in life science research will favor sequencing and analyzer instrument industry, which covered more than 40% of the global digital genome market contribution in 2015. Sample prep instruments, sequencing chip, and RNA or DNA analysis kits are the other notable products in digital genome industry.

Get a Sample Copy of this Report @

China digital genome market size will grow at an annual growth rate of more than 10% over the period of 2016 to 2024. The growth can be attributed to the supportive governmental activities in the favor of human genetic development. Moreover, the strategic partnerships between the biobanks and research institutes will influence the industry share noticeably.

U.S. digital genome market covered over 80% of the North America regional share in 2015 and will generate significant revenue over the coming seven years, owing to the genome sequencing technological enhancements along with availability of advanced healthcare infrastructure.

Brazil digital genome market is anticipated to record a considerable growth rate over the coming timeframe. The supportive rules and regulations regarding genetic and clinical testing will augment the business growth.

Russia digital genome market collected a revenue of around USD 290 million in 2015 and will exhibit lucrative growth over the coming years of 2016 to 2024, primarily driven by the fierce competition prevalent in the region. The Genome Russia project launched by St. Petersburg State University in Russia, aims to collect and scrutinize genome sequences from different regions across the country, which is also expected to generate a noticeable revenue over the coming seven years.

Collaborations, acquisitions, and novel product innovations are the business growth strategies of industry giants. The corporations operating in digital genome market are Becton Dickinson, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Illumina, Pacific Biosciences, Perkin Elmer, Sigma-Aldrich, BioMarin Pharmaceutical, Fluidigm Corporation, Bio-Reference Laboratories, AVEO Oncology, and Agios.

Author Name :Sunil Hebbalkar

Apheresis Equipment Industry to gather an appreciable share via neurology applications, U.S. to be a major revenue pocket

Posted on

Beneficial medical compensation plans for apheresis procedures will be one of the key factors accelerating apheresis equipment market growth. Industry experts are heavily involved in strategic mergers & acquisitions and novel product launches to sustain the competition. Just recently, Terumo, a world leader specializing in cellular and apheresis technology, announced the launch of an innovative apheresis device to treat Myasthenia Gravis (MG) disease and Guillain-Barré syndrome. This device, named Spectra Optia Apheresis System is the first and only device of its kind in Europe that is enabled to treat the aforementioned disorders by means of therapeutic plasma exchange.

The U.S. government makes heavy investments in apheresis research through Medicare, employee insurance, and Medicaid programs. High expenditure on research activities coupled with a steep rise in the number of platelet donors will boost apheresis equipment industry trends. With the introduction of technological advancements, the demand for innovative apheresis devices is expected to surge as well. As per Global Market Insights, Inc., “Apheresis Equipment Industry, which was valued at USD 1.7 billion in 2015, is forecast to hit USD 4.5 billion by 2024.

U.S. Apheresis Equipment Market Size, by procedure, 2012- 2024 (USD Million)

U.S. Apheresis Equipment Market Size, by procedure, 2012- 2024 (USD Million)

High incidences of blood-related disorders such as leukemia and sickle cell anemia coupled with the bulging need for innovative blood component separation techniques will chalk out a profitable roadmap for apheresis equipment industry. An increase in the rate of surgical procedures performed pertaining to the rise in the number of accidents is anticipated to make notable contributions towards the apheresis market revenue.

Apheresis equipment is extensively used in the treatment of neurology, renal diseases, and hematology. Neurology, which accounted for half of apheresis equipment market revenue in 2015, will grow at an annual rate of 12.3% over 2016-2024. Increased occurrence of neurological disorders such as autoimmune disease and multiple sclerosis will drive apheresis equipment industry in neurology applications.

Get a Sample Copy of this Report @

Based on the product trends, apheresis equipment market is classified into disposable apheresis kits and apheresis machines. Disposable apheresis kits dominated the product landscape with a contribution of more than 78% toward apheresis equipment industry share in 2015. Growing popularity along with significantly lower costs will drive the product demand, leading to disposable apheresis equipment market earning a revenue of USD 2,944 million by 2024. Apheresis machines are expected to register significant gains of 17.1% over the coming seven years, driven by escalating requirement for automated component separation equipment.

Europe apheresis equipment market was worth USD 365 million in 2015 and will collect a revenue of more than USD 1,084 million by 2024, owing to the implementation of supportive rules and regulations. Industry giants are also keen to expand their business space across this region, making it an attractive growth avenue. UK and Germany together accounted for more than 27% of the revenue share in 2015.

U.S. apheresis equipment industry contributed majorly toward the North America market size by exceeding a share of 87% in 2015 and will exhibit an annual growth rate of more than 9% over the period of 2016 to 2024. The growth can be attributed to the increasing requirement of automated and technically enhanced products across this region. In addition, the availability of subsidies and refund facilities will also augment the industry growth.

Asia Pacific apheresis equipment market share will generate more than USD 1,265 million by 2024, primarily driven by the surging demand for platelets and plasma pertaining to the increasing prevalence of blood disorders across the emerging countries such as China and India. Japan will also contribute noticeably toward the APAC regional growth as a result of rising adoption of advanced apheresis products along with growing occurrence of cardiovascular diseases.

Strategic partnerships, M&As, and global expansion with major focus on the emerging economies are some of the major business growth strategies adopted by the industry giants. Notable participants in apheresis equipment market are Fresenius Kabi, B.Braun Melsungen, Terumo Corporation, Haemonetics, Kawasumi Laboratories, Therakos, Fenwal Inc, and Hemacare Corporation.

Author Name :Sunil Hebbalkar

China Hydraulic Cylinder Market to witness substantial gains over 2016-2025, heavy investments toward infrastructural development to augment the regional growth

Posted on

Hydraulic Cylinder Market will chart out a lucrative growth path, given that hydraulic cylinders form the backbone of various commercial and industrial applications. These cylinders are also used to manufacture agricultural equipment to enhance agricultural productivity, which will significantly enhance hydraulic cylinder industry growth. In addition, the high rate of investments by developing economies such as India and China are also expected to contribute to the overall business expansion. As per the report by Global Market Insights, Inc., “Hydraulic cylinder market generated a revenue of USD 10 billion in 2015 and will grow at an annual growth rate of more than 6% over the period of 2016 to 2025.”

U.S. Hydraulic Cylinder Market size, by application, 2013 -2025 (Million Units)
 U.S. Hydraulic Cylinder Market size, by application, 2013 -2025 (Million Units)

The prominent application areas of hydraulic cylinder industry are industrial and mobile. Industrial application segment accounted for more than 32% of the revenue share in 2015 and will exhibit a CAGR of above 4% over the coming eight years. Mobile hydraulic cylinder industry dominated the application landscape in 2015 and will generate significant revenue over the years ahead, owing to the increasing product requirement for material handling and agricultural equipment. Additionally, escalating urbanization and increasing construction activities will augment the industry.

Get a Sample Copy of this Report @

Based on the product, hydraulic cylinder market is mainly divided into welded and tie rod. Welded hydraulic cylinder industry will surpass a revenue collection of USD 11 billion by 2025. The extensive use of this product in the construction, mining, industrial, and material handling sectors will augment the market growth noticeably. The surging expansion of the agricultural equipment industry will propel the demand for tie rods, which will grow at an annual growth rate of more than 6% over the period of 2016 to 2025.

Double acting and single acting are the main functional trends of hydraulic cylinder industry. Double acting hydraulic cylinder will collect a revenue above USD 11 billion by 2025, primarily due to the usage of double acting hydraulic cylinders in applications where gravity is the prominent factor, affecting the acceleration and retardation. In addition, double acting function based hydraulic cylinders are extensively used for heavy trucks, forklifting, and earth moving equipment, which will considerably drive overall hydraulic cylinder market share. Single acting hydraulic cylinder market was worth USD 3.12 billion in 2015 and will record substantial growth rate over the coming timeframe.

Geographically, U.S. hydraulic cylinder industry is predicted to generate a revenue of more than USD 3 billion by 2025, owing to heavy investments in the material handling, defense, and aerospace sectors.

China hydraulic cylinder market will collect a revenue of more than USD 1 billion by 2025. The growth can be attributed to the increasing expenditure in infrastructure development. In the years ahead, the Chinese government is willing to invest around USD 151 million in Hubei Xiaogan logistics infrastructure project.

Brazil hydraulic cylinder industry will exhibit an annual growth rate of more than 4% over the period of 2016 to 2025, primarily driven by rising investments in the transportation sector. Russia hydraulic cylinder market will also register a CAGR of more than 3% over the coming eight years. The growth can be attributed to the surging requirement of construction and agricultural equipment.

The key participants in hydraulic cylinder market are Bosch Rexroth AG, Wipro Infrastructure Engineering, Aggressive Inc, Hannon LLC, Best Metal Products, Ligon Industries, LLC, Eaton Corporation PLC, Prince Manufacturing Corporation, Hydrapac Italia, YELETSGIDROAGREGAT, chapel hydraulique, United Hydraulics, Burnside Autocyl (Tullow) Ltd., Bailey International LLC, Enerpac Corp., Baltic, Hyco International, Inc., Caterpillar Inc., Precision group Inc., Norrhydro Oy, Parker-Hannifin Corporation, Weber-Hydraulik Group, Pacoma GmbH, Texas Inc, and Hydrosila.

Author Name :Sunil Hebbalkar

APAC advanced polymer composites market to register the highest growth rate over 2018-2025, strategic business tactics adopted by industry players to augment the product demand

Posted on Updated on

In the last few years, advanced polymer composites market has witnessed a remarkable growth graph with the increasing requirement for composite materials across the aerospace, automotive, and construction sectors. With the favorable advancements in the material science technology, researchers have successfully come up with a new range of products that have become alternatives for already existing metallic materials. These composite materials have nearly similar properties to that of metallic materials, but have far less weight density as compared to metal composites.

U.S. Advanced polymer composites market size, by application, 2014 – 2025 (USD Billion)
U.S. Advanced polymer composites market size, by application, 2014 - 2025 (USD Billion)

In this regard, the aircraft and automotive manufacturers have been giving preference for these materials for achieving higher fuel efficiency. Taking into account the demand for advanced polymer composites, key industry players have been looking forward to extending their product portfolio and regional reach. Tried-and-tested as well as out0of-the-box tactics adopted by companies to consolidate their position in the market is slated to expedite the advanced polymer composites industry size.

Recently in May 2018, the well-known aeronautical company, Airbus offered a long-term contract to Teledyne CML Composites to supply composite wings components and assemblies to its commercial airliner. In this contract, the UK based composite manufacturer will provide long range of composite parts for Airbus’ A350-900 and A350-1000 aircraft wings. In order to manufacture both – the wings structure and fuselage of the A350 series aircraft, it has used a carbon-fiber reinforced polymer that will reduce the maintenance cost and improves components’ resistance to corrosion. After receiving the long-term contract from Airbus, Teledyne CML Composites has considerably improved the quality of its composite parts that will help it to gain access to new business opportunities from several other end-users.

Get a Sample Copy of this Report @

As of now, numerous companies have been replacing metals with polymer composites for reducing the overall weight of the product assembly. In line with the increasing demand for polymer composites, polymer manufacturers have been focusing on new product developments, capacity expansions, and mergers & acquisitions. Validating the aforementioned fact, in the middle of 2018, Mitsui Chemicals Inc. decided to establish its long glass fiber reinforced polypropylene (LGFPP) production facility in the U.S. pertaining to the growing demand for fiber-reinforced resins across North America. This would considerably augment the commercialization potential of North America advanced polymer composites industry, which as per estimates, held 35% of the overall market share in 2017.

Speaking along the same line, Mitsui Chemicals will start its commercial operation by October 2019 with the production capacity of 3500 tons per year that will turn out to be rather beneficial for leading automakers. Owing to the excellent impact resistance, lightweight, better appearance, and hardness, LGFPP is preferred for automotive applications. In the last few years, with the increasing popularity of electric vehicles along with the deployment of strict environmental norms, the demand for LGFPP has increased remarkably. Reportedly, in line with the surging demand for automobiles across India and China, APAC advanced polymer composites market will register a CAGR of more than 8% over 2018-2025.

In addition to capacity expansions, several other contributors in the advanced polymer composites industry have been looking forward to enhancing their product portfolio with the strategic mergers and acquisitions. For instance, in June 2018, global provider of specialized polymer material, PolyOne has acquired leading manufacturer of high-performance and advanced composites, PlastiComp. This deal will become fruitful for PolyOne to improve its existing portfolio, aided by PlastiComp’s expertise in the long fiber technology. In the future, PolyOne is planning to launch unique and long fiber technology composite formulations to expand its customer base. The strategies adopted by the players in the advanced polymer composites market to focus on the diverse application scope is poised to boost the industry growth over the years ahead.

The collaborative approach undertaken between the OEMs and product suppliers in line with the on-going product innovation and design changes is likely to impel advanced polymer composites industry trends. The shifting trends toward the development of lightweight components for improving the fuel efficiency and curbing emission also will have a positive impact on the product demand. Reportedly, advanced polymer composites market will surpass a revenue collection of USD 17 billion by the end of 2025.

Author Name :Sunil Hebbalkar